Valuation: Vext Science, Inc.

Market Cap 31.29M 28.35M 26.22M 23.66M 44.59M 2.95B 46.16M 315M 125M 1.58B 117M 115M 5B P/E 2026 *
-4.29x
P/E 2027 * 25.7x
Enterprise Value 60.66M 54.97M 50.85M 45.88M 86.45M 5.72B 89.5M 611M 242M 3.06B 228M 223M 9.7B EV / Sales 2026 *
1.12x
EV / Sales 2027 * 0.77x
Free-Float
40.74%
Yield 2026 *
-
Yield 2027 * -
1 day-12.20%
1 week-20.00%
Current month-26.53%
1 month-21.74%
3 months-33.33%
6 months-38.98%
Current year-29.41%
1 week 0.18
Extreme 0.18
0.22
1 month 0.18
Extreme 0.18
0.26
Current year 0.18
Extreme 0.18
0.4
1 year 0.18
Extreme 0.18
0.4
3 years 0.1
Extreme 0.1
0.42
5 years 0.1
Extreme 0.1
0.92
10 years 0.1
Extreme 0.1
2.1
Manager TitleAgeSince
Chief Executive Officer - 2020-02-17
Director of Finance/CFO - 2023-08-24
Investor Relations Contact - -
Director TitleAgeSince
Chairman 45 2015-12-10
Director/Board Member - 2020-02-13
Chairman 69 2024-08-19
Date Insider Type Main position Quantity % Market Cap. Importance
1/5/26 Sell

Director

1,334,000 0.8075%
1/5/26 Sell

Founder

20,340 2.9973%
1/5/26 Other

Director

0 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
-12.20%-20.00%-25.00%-44.62% 31.29M
-0.49%+6.56%+12.76%+31.78% 114B
-0.32%+0.82%+5.44%+116.99% 104B
-1.19%+2.71%+59.01%+557.38% 46.27B
+0.89%+1.54%+8.69%+105.75% 33.33B
-0.49%+1.07%+38.31%+81.24% 30.08B
-0.02%+1.55%+38.39%+96.15% 28.56B
-0.29%+0.95%+45.44%+421.29% 22.76B
+0.33%-1.02%-18.35%-17.59% 19.92B
+1.15%+2.99%-3.88%+34.63% 17.15B
Average -1.26%-0.28%+16.08%+138.30% 42B
Weighted average by Cap. -0.27%+2.74%+18.95%+144.40%

Financials

2026 *2027 *
Net sales 54.4M 49.3M 45.6M 41.14M 77.53M 5.13B 80.26M 548M 217M 2.74B 204M 200M 8.7B 65.36M 59.23M 54.79M 49.43M 93.15M 6.16B 96.44M 658M 261M 3.29B 245M 240M 10.45B
Net income -8.2M -7.43M -6.87M -6.2M -11.69M -773M -12.1M -82.56M -32.74M -413M -30.77M -30.12M -1.31B 1.02M 925K 855K 772K 1.45M 96.22M 1.51M 10.28M 4.07M 51.4M 3.83M 3.75M 163M
Net Debt 29.38M 26.62M 24.62M 22.22M 41.87M 2.77B 43.34M 296M 117M 1.48B 110M 108M 4.7B 19.13M 17.34M 16.04M 14.47M 27.27M 1.8B 28.23M 193M 76.39M 964M 71.8M 70.28M 3.06B
Projected Income Statement - Annual - Vext Science, Inc.
Logo Vext Science, Inc.
Vext Science, Inc. is a cannabis operator with vertical operations in Arizona and Ohio. The Company's expertise spans from cultivation through to retail operations in its key markets. The Company owns and operates cultivation facilities, fully built-out manufacturing facilities as well as dispensaries in both Arizona and Ohio. The Company produces a range of branded offerings, including its Vapen, Revibe, Herbal Wellness Center, and Appalachian Pharm lines. The Company manufactures Vapen, one of the THC concentrates, edibles, and distillate cartridge brands in Arizona. It produces CBD products under the Vapen CBD and Hempy Endings brands, manufactured at its Vapen Kentucky facility. Through strategic licensing agreements, it manufactures the Microbar brand in Arizona. The Company extends its services to the cannabis industry by offering management, advisory, cultivation, non-cannabis products, and dispensary services through operating agreements and direct sales to various entities.
Employees
-
Date Price Change Volume
26-11-13 CA$0.1800 -12.20% 122,500
26-11-12 CA$0.2050 -6.82% 106,000
26-11-10 CA$0.2200 +7.32% 34,500
26-11-09 CA$0.2050 -8.89% 17,500
26-11-06 CA$0.2250 +12.50% 19,050
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Vext Science, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.1800CAD
Average target price
0.9500CAD
Spread / Average Target
+427.78%
  1. Stock Market
  2. Stocks
  3. VEXT Stock